B-1 (CD 5+) B-cells as a marker of immune dysregulation in multiple myeloma.
MacKenzie
M R
MR
Division of Hematology and Oncology, University of California, Davis School of Medicine.
Paglieroni
T G
TG
D000755:Anemia, Sickle Cell / Q000097:blood / Q000628:therapy; D015703:Antigens, CD / Q000032:analysis*; D016175:B-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis*; D001803:Blood Transfusion; D018956:CD5 Antigens; D002469:Cell Separation; D006801:Humans; D007108:Immune Tolerance; D007075:Immunoglobulin M / Q000097:blood; D008221:Lymphoid Tissue / Q000473:pathology; D018448:Models, Immunological; D009101:Multiple Myeloma / Q000097:blood / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009363:Neoplasm Proteins / Q000032:analysis*; D010265:Paraproteinemias / Q000276:immunology / Q000473:pathology; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D014408:Biomarkers, Tumor; D018956:CD5 Antigens; D007075:Immunoglobulin M; D009363:Neoplasm Proteins